Dr Eric Karran (Director of Research: Alzheimer’s Research UK)

Academic drug discovery in neurodegeneration; a new approach to an ageing problem

10 June 2015 | By Dr Eric Karran (Director of Research: Alzheimer’s Research UK)

Dementia is a global crisis with 76 million people worldwide expected to be living with the condition by 2030. Current symptomatic treatments provide modest improvements in cognition but disease-modifying therapies for diseases like Alzheimer’s – the most common cause of dementia – do not yet exist.